Guillaume Fond
Guillaume Fond
Aix-Marseille Univ, School of medicine - La Timone Medical Campus, EA 3279: CEReSS - Health Service
Verified email at inserm.fr - Homepage
TitleCited byYear
Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis
G Fond, A Loundou, N Hamdani, W Boukouaci, A Dargel, J Oliveira, ...
European archives of psychiatry and clinical neuroscience 264 (8), 651-660, 2014
1962014
Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta‐analysis
AL Sutterland, G Fond, A Kuin, MWJ Koeter, R Lutter, T Van Gool, ...
Acta Psychiatrica Scandinavica 132 (3), 161-179, 2015
1922015
Ketamine administration in depressive disorders: a systematic review and meta-analysis
G Fond, A Loundou, C Rabu, A Macgregor, C Lançon, M Brittner, ...
Psychopharmacology 231 (18), 3663-3676, 2014
1842014
Effectiveness and tolerance of anti‐inflammatory drugs' add‐on therapy in major mental disorders: a systematic qualitative review
G Fond, N Hamdani, F Kapczinski, W Boukouaci, N Drancourt, A Dargel, ...
Acta Psychiatrica Scandinavica 129 (3), 163-179, 2014
1192014
The “psychomicrobiotic”: Targeting microbiota in major psychiatric disorders: A systematic review
G Fond, W Boukouaci, G Chevalier, A Regnault, G Eberl, N Hamdani, ...
Pathologie Biologie 63 (1), 35-42, 2015
1182015
EEG neurofeedback treatments in children with ADHD: an updated meta-analysis of randomized controlled trials
JA Micoulaud-Franchi, PA Geoffroy, G Fond, R Lopez, S Bioulac, P Philip
Frontiers in human neuroscience 8, 906, 2014
1012014
Fasting in mood disorders: neurobiology and effectiveness. A review of the literature
G Fond, A Macgregor, M Leboyer, A Michalsen
Psychiatry research 209 (3), 253-258, 2013
692013
The promise of biological markers for treatment response in first-episode psychosis: a systematic review
G Fond, MA d’Albis, S Jamain, R Tamouza, C Arango, WW Fleischhacker, ...
Schizophrenia bulletin 41 (3), 559-573, 2015
622015
The prevalence of mental disorders among children and adolescents in the child welfare system: A systematic review and meta-analysis
G Bronsard, M Alessandrini, G Fond, A Loundou, P Auquier, S Tordjman, ...
Medicine 95 (7), 2016
552016
Antipsychotic drugs: pro-cancer or anti-cancer? A systematic review
G Fond, A Macgregor, J Attal, A Larue, M Brittner, D Ducasse, ...
Medical hypotheses 79 (1), 38-42, 2012
502012
A further evaluation of decision-making under risk and under ambiguity in schizophrenia
G Fond, S Bayard, D Capdevielle, J Del-Monte, N Mimoun, A Macgregor, ...
European archives of psychiatry and clinical neuroscience 263 (3), 249-257, 2013
432013
A structural equation modelling approach to explore the determinants of quality of life in schizophrenia
M Alessandrini, C Lançon, G Fond, C Faget-Agius, R Richieri, M Faugere, ...
Schizophrenia research 171 (1-3), 27-34, 2016
402016
A National network of schizophrenia expert centres: an innovative tool to bridge the research-practice gap
F Schürhoff, G Fond, F Berna, E Bulzacka, J Vilain, D Capdevielle, ...
European Psychiatry 30 (6), 728-735, 2015
402015
Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate
G Fond, A Macgregor, R Tamouza, N Hamdani, A Meary, M Leboyer, ...
European archives of psychiatry and clinical neuroscience 264 (2), 179-183, 2014
372014
Chronic peripheral inflammation is associated with cognitive impairment in schizophrenia: results from the multicentric FACE-SZ dataset
E Bulzacka, L Boyer, F Schürhoff, O Godin, F Berna, L Brunel, ...
Schizophrenia bulletin 42 (5), 1290-1302, 2016
362016
Toxoplasma gondii: A potential role in the genesis of psychiatric disorders.
G Fond, D Capdevielle, A Macgregor, J Attal, A Larue, M Brittner, ...
L'Encéphale, epub ahead of print, 2012
292012
Cognitive insight as an indicator of competence to consent to treatment in schizophrenia
S Raffard, G Fond, M Brittner, C Bortolon, A Macgregor, JP Boulenger, ...
Schizophrenia research 144 (1-3), 118-121, 2013
272013
Treatment with anti-toxoplasmic activity (TATA) for toxoplasma positive patients with bipolar disorders or schizophrenia: a cross-sectional study
G Fond, L Boyer, A Gaman, H Laouamri, D Attiba, JR Richard, M Delavest, ...
Journal of psychiatric research 63, 58-64, 2015
262015
Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: results from the FACE-SZ cohort
O Godin, M Leboyer, A Gaman, B Aouizerate, F Berna, L Brunel, ...
Schizophrenia research 168 (1-2), 388-394, 2015
252015
D2 and D3 dopamine receptor affinity predicts effectiveness of antipsychotic drugs in obsessive-compulsive disorders: a metaregression analysis
D Ducasse, L Boyer, P Michel, A Loundou, A Macgregor, ...
Psychopharmacology 231 (18), 3765-3770, 2014
252014
The system can't perform the operation now. Try again later.
Articles 1–20